Financial Architects, Inc Novartis Ag Transaction History

Financial Architects, Inc

$657 Million
Q2 2023

A detailed history of Financial Architects, Inc transactions in Novartis Ag stock. As of the latest transaction made, Financial Architects, Inc holds 8,679 shares of NVS stock, worth $894,284. This represents 0.13% of its overall portfolio holdings.

Number of Shares

8,679

Previous 8,807 1.45%

Holding current value

$894,284

Previous $810,000 8.02%

% of portfolio

0.13%

Previous 0.13%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$92.52 - $104.91 $11,842 - $13,428	-128 Reduced 1.45%	8,679 $875,000
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $59,222 - $68,679	-740 Reduced 7.75%	8,807 $810,000
Q4 2022 Feb 06, 2023	SELL	$75.55 - $92.52 $9,594 - $11,750	-127 Reduced 1.31%	9,547 $866,000
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $721,777 - $844,153	9,674 New	9,674 $735,000
Q2 2022 Aug 11, 2022	SELL	$80.52 - $93.75 $794,168 - $924,656	-9,863 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$80.11 - $90.62 $128,176 - $144,992	-1,600 Reduced 13.96%	9,863 $865,000
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $53,638 - $59,311	-673 Reduced 5.55%	11,463 $1 Million
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $19,300 - $22,453	-236 Reduced 1.91%	12,136 $992,000
Q2 2021 Aug 10, 2021	SELL	$85.24 - $94.15 $40,403 - $44,627	-474 Reduced 3.69%	12,372 $1.13 Million
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $8,266 - $9,748	-99 Reduced 0.76%	12,846 $1.1 Million
Q4 2020 Feb 17, 2021	SELL	$78.07 - $94.43 $21,469 - $25,968	-275 Reduced 2.08%	12,945 $1.22 Million
Q3 2020 Nov 09, 2020	SELL	$82.14 - $91.0 $13,306 - $14,742	-162 Reduced 1.21%	13,220 $1.15 Million
Q2 2020 Aug 11, 2020	SELL	$80.93 - $91.1 $8,497 - $9,565	-105 Reduced 0.78%	13,382 $1.17 Million
Q1 2020 May 07, 2020	SELL	$70.67 - $99.01 $1,484 - $2,079	-21 Reduced 0.16%	13,487 $1.11 Million
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $28,004 - $31,662	-332 Reduced 2.4%	13,508 $1.28 Million
Q3 2019 Nov 06, 2019	SELL	$85.54 - $94.26 $47,731 - $52,597	-558 Reduced 3.88%	13,840 $1.2 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $29,481 - $36,284	-391 Reduced 2.64%	14,398 $1.32 Million
Q1 2019 May 13, 2019	BUY	$75.32 - $86.15 $1.04 Million - $1.18 Million	13,749 Added 1322.02%	14,789 $1.42 Million
Q1 2019 May 03, 2019	SELL	$75.32 - $86.15 $1.05 Million - $1.2 Million	-13,975 Reduced 93.07%	1,040 $100,000
Q4 2018 Feb 01, 2019	BUY	$73.66 - $82.02 $9,207 - $10,252	125 Added 0.84%	15,015 $1.29 Million
Q3 2018 Oct 29, 2018	SELL	$66.94 - $77.43 $10,041 - $11,614	-150 Reduced 1.0%	14,890 $1.28 Million
Q2 2018 Aug 03, 2018	SELL	$64.91 - $73.36 $86,070 - $97,275	-1,326 Reduced 8.1%	15,040 $1.14 Million
Q1 2018 Apr 23, 2018	SELL	$70.39 - $84.15 $98,686 - $117,978	-1,402 Reduced 7.89%	16,366 $1.32 Million
Q4 2017 Feb 12, 2018	BUY	$72.33 - $77.64 $2,676 - $2,872	37 Added 0.21%	17,768 $1.49 Million
Q3 2017 Nov 01, 2017	BUY	$74.14 - $77.27 $1.24 Million - $1.29 Million	16,691 Added 1604.9%	17,731 $1.52 Million
Q3 2017 Oct 23, 2017	BUY	$74.14 - $77.27 $77,105 - $80,360	1,040	1,040 $89,000

Others Institutions Holding NVS

# of Institutions

1,433

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Architects, Inc with notifications on news.

Account

Financial Architects, Inc Novartis Ag Transaction History